Nicholas Verdini, MD (@nick_verdini) 's Twitter Profile
Nicholas Verdini, MD

@nick_verdini

Transitional Year PGY-1 | Future RadOnc Resident at Stanford ☢️ | Tufts School of Medicine Alum

ID: 747753658931093504

calendar_today28-06-2016 11:28:59

355 Tweet

292 Followers

542 Following

Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo

☢️🦴 In a multi-center RCT ⚖️ (n=78), radiation to high-risk asymptomatic bone metastases ⬇️ skeletal-related events and prolonged overall survival in metastatic solid tumors: brnw.ch/21wE43a #radonc Erin Gillespie, MD MPH

☢️🦴 In a multi-center RCT ⚖️ (n=78), radiation to high-risk asymptomatic bone metastases ⬇️ skeletal-related events and prolonged overall survival in metastatic solid tumors: brnw.ch/21wE43a #radonc <a href="/ErinGillespieMD/">Erin Gillespie, MD MPH</a>
Erin Gillespie, MD MPH (@eringillespiemd) 's Twitter Profile Photo

Radiation to asymptomatic bone metastases reduces SREs (incl fractures, cord compression). Primary results of our phase 2 RCT ⚖️ were published (below). If you don’t have access to the full manuscript 📑, please DM me. 🙏 #radonc #medonc

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Substance use disorders (SUD) prevalence is higher among survivors of certain types of cancer, suggests cross-sectional study. This information could be used to identify cancer survivors who may benefit from integrated cancer and SUD care. ja.ma/48MFTMp IMD

Memorial Sloan Kettering Radiation Oncology (@msk_radonc) 's Twitter Profile Photo

New by PGY2 Dr Nikhil Mankuzhy, MD with Dr Suzanne Wolden: Re-irradiation with hypofractionation for locally recurrent diffuse intrinsic pontine glioma #DIPG achieved survival duration comparable to published outcomes & effectively palliated symptoms. #pedcsm onlinelibrary.wiley.com/doi/10.1002/pb…

New by PGY2 Dr <a href="/NikMankuzhy/">Nikhil Mankuzhy, MD</a> with Dr Suzanne Wolden:  Re-irradiation with hypofractionation for locally recurrent diffuse intrinsic pontine glioma #DIPG achieved survival duration comparable to published outcomes &amp; effectively palliated symptoms. #pedcsm 
onlinelibrary.wiley.com/doi/10.1002/pb…
Applied Radiation Oncology (@applied_radonc) 's Twitter Profile Photo

📢 All new Student Scan out now! Check out hot topics in #RadiationOncology, an interview with Jillian Gunther MD, PhD, opportunities for career development, and more! Check it out ➡️ bit.ly/4aAW68L @lauramaule3 Josh Qian Sylvia Choo Anthony Alanis #RadOncEd #MedEd

📢 All new Student Scan out now! 
Check out hot topics in #RadiationOncology, an interview with <a href="/JillGunther/">Jillian Gunther</a> MD, PhD, opportunities for career development, and more!

Check it out ➡️ bit.ly/4aAW68L
@lauramaule3 <a href="/RadQian/">Josh Qian</a> <a href="/SylviaChoo5/">Sylvia Choo</a> <a href="/AnthonyAlanis01/">Anthony Alanis</a>
#RadOncEd #MedEd
Nicholas Verdini, MD (@nick_verdini) 's Twitter Profile Photo

Our paper, “When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians” is out now in JCO Oncology Practice! ascopubs.org/doi/10.1200/OP… Tony Hung Erin Gillespie, MD MPH

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Using ePROs to prompt direct patient trial invitations resulted in greater enrollment to a symptom-intervention trial than standard of care physician-based referral. Nicholas Verdini, MD Jun J. Mao Erin Gillespie, MD MPH Memorial Sloan Kettering Radiation Oncology ja.ma/3KTTGXW

Andrea Apolo, M.D. (@apolo_andrea) 's Twitter Profile Photo

Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo & Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi published Journal of Clinical Oncology, that includes #rareGUtumors & took years to complete but laid the foundation for many future trials in oncology gcc02.safelinks.protection.outlook.com/?url=https%3A%…

Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo &amp; Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi published <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>, that includes #rareGUtumors &amp; took years to complete but laid the foundation for many future trials in oncology gcc02.safelinks.protection.outlook.com/?url=https%3A%…
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

☢️Celiac plexus radiation for pain management in pancreatic cancer The Lancet Oncology ✅At 3 weeks, 53% of the patients had at least a partial pain response ✅A non-invasive, relatively safe treatment 👉doi.org/10.1016/S1470-… The Lancet ESTRO ASTRO PanCAN M. Bolton

☢️Celiac plexus radiation for pain management in pancreatic cancer
<a href="/TheLancetOncol/">The Lancet Oncology</a> 

✅At 3 weeks, 53% of the patients had at least a partial pain response

✅A non-invasive, relatively safe treatment 

👉doi.org/10.1016/S1470-…

<a href="/TheLancet/">The Lancet</a> <a href="/ESTRO_RT/">ESTRO</a> <a href="/ASTRO_org/">ASTRO</a> <a href="/PanCAN/">PanCAN</a> <a href="/5_utr/">M. Bolton</a>
Drew T Bergman, MD (@dtbergman) 's Twitter Profile Photo

Proud to share our work compiling the landscape of funded #RadOnc away rotations for medical students! Pls RT to spread the word to help out budding #RadOncs! link.springer.com/article/10.100…

Rehema J. Thomas, MD (@radiantrehemamd) 's Twitter Profile Photo

Congrats to Nicholas Verdini, MD on his receipt of the ARRO/ROI joint DEI Publication Award, recognizing a trainee who has published work on a topic related to DEI. Nick investigated PROs as a recruitment strategy for trial enrollment. 🏆🔥 Stanford Radiation Oncology Radiation Oncology Institute-The ASTRO Foundation ARRO

Congrats to <a href="/nick_verdini/">Nicholas Verdini, MD</a> on his receipt of the ARRO/ROI joint DEI Publication Award, recognizing a trainee who has published work on a topic related to DEI. Nick investigated PROs as a recruitment strategy for trial enrollment. 🏆🔥
<a href="/StanfordRadOnc/">Stanford Radiation Oncology</a> <a href="/RO_Institute/">Radiation Oncology Institute-The ASTRO Foundation</a> <a href="/ARRO_org/">ARRO</a>
Stanford Radiation Oncology Residents (@stanfordro_res) 's Twitter Profile Photo

Thrilled to welcome our new Stanford Radiation Oncology Residents residents to our family!! 🎉 Huge congratulations to Kathryn Achuck, Nicholas Mullen, Amira Osman-Short, and Sarah Seiter! We’re THRILLED to have you all join the Stanford family! #RadOnc #Match2025 Stanford Medicine Stanford Radiation Oncology

Thrilled to welcome our new <a href="/StanfordRO_Res/">Stanford Radiation Oncology Residents</a> residents to our family!! 🎉

Huge congratulations to Kathryn Achuck, Nicholas Mullen, Amira Osman-Short, and Sarah Seiter! 

We’re THRILLED to have you all join the Stanford family! #RadOnc #Match2025 <a href="/StanfordMed/">Stanford Medicine</a> <a href="/StanfordRadOnc/">Stanford Radiation Oncology</a>